ArticleCells2026
Protein Expression Analysis and Functional Characterization of Sorcin in Gallbladder Cancer.
Vaishali Jain, Neeraj Saklani, Srishti Kawatra, Puja Sakhuja, Surbhi Goyal, Anil Kumar Agarwal, Parveen Kumar, Fouzia Siraj, Poonam Gautam
Abstract read
In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Vaishali JainICMR-Centre for Cancer Pathology (Formerly a Part of ICMR-National Institute of Pathology), Safdarjung Hospital Campus, New Delhi 110029, India.
Neeraj SaklaniICMR-Centre for Cancer Pathology (Formerly a Part of ICMR-National Institute of Pathology), Safdarjung Hospital Campus, New Delhi 110029, India.
Srishti KawatraICMR-Centre for Cancer Pathology (Formerly a Part of ICMR-National Institute of Pathology), Safdarjung Hospital Campus, New Delhi 110029, India.
Puja SakhujaDepartment of Pathology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research (GIPMER), New Delhi 110002, India.ORCID 0000-0001-7286-5941 Surbhi GoyalDepartment of Pathology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research (GIPMER), New Delhi 110002, India.
Anil Kumar AgarwalDepartment of Surgery, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research (GIPMER), New Delhi 110002, India.
Parveen KumarICMR-Centre for Cancer Pathology (Formerly a Part of ICMR-National Institute of Pathology), Safdarjung Hospital Campus, New Delhi 110029, India.ORCID 0000-0001-6857-2425 Fouzia SirajICMR-Centre for Cancer Pathology (Formerly a Part of ICMR-National Institute of Pathology), Safdarjung Hospital Campus, New Delhi 110029, India.ORCID 0000-0001-7643-7936 Poonam GautamICMR-Centre for Cancer Pathology (Formerly a Part of ICMR-National Institute of Pathology), Safdarjung Hospital Campus, New Delhi 110029, India.ORCID 0000-0002-3804-6157 Funding
Anusandhan National Research Foundation (ANRF), Govt. of India Project ID- CRG/2020/002100Indian Council of Medical Research (ICMR), Govt. of India Project ID-79/I/IIRP-NIOP/Onco/2023-NCD-III
6 · The paper itselfAbstract
Gallbladder cancer (GBC) is an aggressive malignancy with limited treatment options and poor clinical outcomes. Identifying novel molecular targets is critical for improving therapeutic strategies. Sorcin (
Indexed as
Calcium-Binding ProteinsGallbladder NeoplasmsAgedCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNeoplasm InvasivenessCalcium-Binding ProteinsSRI protein, humanepithelial–mesenchymal transitiongallbladder cancerimmunohistochemistrySorcintherapeutic target
Identifiers
PMID42041546
PMCPMC13115428
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390